Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ota Fuchs

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
European Journal of Haematology|October 7, 2014
High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomideAnna Jonasova, Radka Bokorova, Jaroslav Polak, et al.
Journal of Hematology & Oncology|October 1, 2014
CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemiaHana Hájková, Markus Hsi-Yang Fritz, Cedrik Haškovec, et al.
Blood Cells, Molecules & Diseases|January 10, 2008
CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphomaOta Fuchs, Dana Provaznikova, Marcela Kocova, et al.
Blood Cells, Molecules & Diseases|August 5, 2009
Nature of frequent deletions in CEBPAOta Fuchs, Arnost Kostecka, Dana Provaznikova, et al.
Annals of Hematology|September 12, 2012
Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemiaRadana Neuwirtova, Ota Fuchs, Monika Holicka, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
European Journal of Haematology|October 7, 2014
High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomideAnna Jonasova, Radka Bokorova, Jaroslav Polak, et al.
Journal of Hematology & Oncology|October 1, 2014
CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemiaHana Hájková, Markus Hsi-Yang Fritz, Cedrik Haškovec, et al.
Blood Cells, Molecules & Diseases|January 10, 2008
CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphomaOta Fuchs, Dana Provaznikova, Marcela Kocova, et al.
Blood Cells, Molecules & Diseases|August 5, 2009
Nature of frequent deletions in CEBPAOta Fuchs, Arnost Kostecka, Dana Provaznikova, et al.
Annals of Hematology|September 12, 2012
Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemiaRadana Neuwirtova, Ota Fuchs, Monika Holicka, et al.
Pageof 3